These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23072543)

  • 1. Five-year outcomes in living donor kidney transplants with a positive crossmatch.
    Bentall A; Cornell LD; Gloor JM; Park WD; Gandhi MJ; Winters JL; Chedid MF; Dean PG; Stegall MD
    Am J Transplant; 2013 Jan; 13(1):76-85. PubMed ID: 23072543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive crossmatch kidney transplant recipients treated with eculizumab: outcomes beyond 1 year.
    Cornell LD; Schinstock CA; Gandhi MJ; Kremers WK; Stegall MD
    Am J Transplant; 2015 May; 15(5):1293-302. PubMed ID: 25731800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in chronic intragraft inflammation between positive crossmatch and ABO-incompatible kidney transplantation.
    Bentall A; Herrera LP; Cornell LD; Gonzales MA; Dean PG; Park WD; Gandhi MJ; Winters JL; Stegall MD
    Transplantation; 2014 Nov; 98(10):1089-96. PubMed ID: 24911035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
    Opelz G; Morath C; Süsal C; Tran TH; Zeier M; Döhler B
    Transplantation; 2015 Feb; 99(2):400-4. PubMed ID: 25050471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. The implications for graft survival.
    ten Hoor GM; Coopmans M; Allebes WA
    Transplantation; 1993 Aug; 56(2):298-304. PubMed ID: 7689256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early subclinical inflammation correlates with outcomes in positive crossmatch kidney allografts.
    Dean PG; Park WD; Cornell LD; Schinstock CA; Stegall MD
    Clin Transplant; 2016 Aug; 30(8):925-33. PubMed ID: 27225518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1996; ():1-14. PubMed ID: 9286555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luminex Solid-Phase Crossmatch for De Novo Donor-Specific Antibodies in Living-Donor Related Transplants.
    Mehrotra S; Sharma RK; Mayya M; Gupta A; Prasad N; Kaul A; Bhadauria DS
    Exp Clin Transplant; 2017 Aug; 15(4):394-399. PubMed ID: 28447925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximab.
    Kahwaji J; Jordan SC; Najjar R; Wongsaroj P; Choi J; Peng A; Villicana R; Vo A
    Transpl Int; 2016 Dec; 29(12):1276-1285. PubMed ID: 27529314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype.
    Bryan CF; Martinez J; Muruve N; Nelson PW; Pierce GE; Ross G; Shield CF; Warady BA; Aeder MI; Harrell KM; Helling TS; Luger AM
    Clin Transplant; 2001; 15 Suppl 6():28-35. PubMed ID: 11903383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
    Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of eculizumab-treated positive crossmatch recipients: Allograft survival, histologic findings, and natural history of the donor-specific antibodies.
    Schinstock CA; Bentall AJ; Smith BH; Cornell LD; Everly M; Gandhi MJ; Stegall MD
    Am J Transplant; 2019 Jun; 19(6):1671-1683. PubMed ID: 30412654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Center and other factor effects in recipients of living-donor kidney transplants.
    Gjertson DW
    Clin Transpl; 2001; ():209-21. PubMed ID: 12211785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching.
    Bryan CF; Baier KA; Nelson PW; Luger AM; Martinez J; Pierce GE; Ross G; Shield CF; Warady BA; Aeder MI; Helling TS; Muruve N
    Transplantation; 1998 Dec; 66(12):1827-32. PubMed ID: 9884283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
    Cai J
    Clin Transpl; 2009; ():83-101. PubMed ID: 20524278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplant outcomes in positive complement-dependent cytotoxicity- versus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: a retrospective study.
    Kim DG; Lee J; Park Y; Kim MS; Jeong HJ; Kim SI; Kim YS; Kim BS; Huh KH
    BMC Nephrol; 2019 Dec; 20(1):456. PubMed ID: 31818254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The OPTN/UNOS Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 2005; ():1-16. PubMed ID: 17424721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.